Top 15 highest paid biopharma R&D chiefs

Being an R&D chief at a major biopharma company in today's environment of major research cutbacks, patent expirations and pressure from investors to speed new drugs to market is no easy task--and that's why the world's top drug research gurus are bringing in the big bucks.

 

We sifted through proxy statements and other public documents for the financial details on pay for some of the most powerful R&D players in the industry. Combined, these 15 highest-paid R&D execs earned about $144.3 million in 2012, compared with $69.1 million in 2011, a 109% increase.